Cargando…
Ibuprofen use and clinical outcomes in COVID-19 patients
OBJECTIVE: It was recently suggested that ibuprofen might increase the risk for severe and fatal coronavirus disease 2019 (COVID-19) and should therefore be avoided in this patient population. We aimed to evaluate whether ibuprofen use in individuals with COVID-19 was associated with more severe dis...
Autores principales: | Rinott, E., Kozer, E., Shapira, Y., Bar-Haim, A., Youngster, I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289730/ https://www.ncbi.nlm.nih.gov/pubmed/32535147 http://dx.doi.org/10.1016/j.cmi.2020.06.003 |
Ejemplares similares
-
Reduction in COVID-19 Patients Requiring Mechanical Ventilation Following Implementation of a National COVID-19 Vaccination Program — Israel, December 2020–February 2021
por: Rinott, Ehud, et al.
Publicado: (2021) -
In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease
por: Veljkovic, Veljko, et al.
Publicado: (2015) -
Does Ibuprofen Worsen COVID-19?
por: Moore, Nicholas, et al.
Publicado: (2020) -
Safety of Ibuprofen in Patients With COVID-19: Causal or Confounded?
por: Sodhi, Mohit, et al.
Publicado: (2020) -
Hydrolysis of Ibuprofen Nitrile and Ibuprofen Amide and Deracemisation of Ibuprofen Using Nocardia corallina B-276
por: Lievano, Ricardo, et al.
Publicado: (2012)